HCW Biologics reported Q1 2025 revenue of $5.1K (-99.6% YoY). Diluted EPS came in at $-0.05 (+99.4% YoY).
Trailing eight quarters through Q1 2025
Common questions about HCW Biologics's Q1 2025 earnings report.
HCW Biologics (HCWB) reported Q1 2025 earnings on May 15, 2025 before market open.
HCW Biologics reported revenue of $5.1K and diluted EPS of $-0.05 for Q1 2025.
Compared to the same quarter a year prior, revenue declined 99.6% from $1.1M a year earlier and diluted EPS grew 99.4% from $-8.00.
You can read the 10-Q periodic report (0000950170-25-072833) directly on SEC EDGAR. The filing index links above go to sec.gov.